$0.57 EPS Expected for Envision Healthcare Co. (EVHC) This Quarter
Wall Street analysts expect Envision Healthcare Co. (NYSE:EVHC) to report earnings per share of $0.57 for the current fiscal quarter, according to Zacks Investment Research. Seven analysts have issued estimates for Envision Healthcare’s earnings, with the highest EPS estimate coming in at $0.99 and the lowest estimate coming in at $0.45. Envision Healthcare reported earnings of $1.15 per share in the same quarter last year, which indicates a negative year-over-year growth rate of 50.4%. The business is expected to announce its next earnings results on Tuesday, February 27th.
On average, analysts expect that Envision Healthcare will report full-year earnings of $2.85 per share for the current year, with EPS estimates ranging from $2.68 to $3.39. For the next financial year, analysts expect that the business will report earnings of $3.19 per share, with EPS estimates ranging from $2.54 to $3.80. Zacks’ EPS calculations are an average based on a survey of sell-side research firms that follow Envision Healthcare.
Envision Healthcare (NYSE:EVHC) last issued its quarterly earnings results on Tuesday, October 31st. The company reported $0.73 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.81 by ($0.08). Envision Healthcare had a negative net margin of 6.39% and a positive return on equity of 4.88%. The firm had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $2.03 billion. During the same quarter last year, the firm posted $1.13 earnings per share. Envision Healthcare’s revenue was up 142.0% compared to the same quarter last year.
A number of hedge funds have recently made changes to their positions in EVHC. Commonwealth Bank of Australia boosted its position in Envision Healthcare by 24.3% during the 2nd quarter. Commonwealth Bank of Australia now owns 2,096 shares of the company’s stock worth $130,000 after acquiring an additional 410 shares during the period. LMR Partners LLP acquired a new position in Envision Healthcare during the 2nd quarter worth $205,000. Palisade Capital Management LLC NJ acquired a new position in Envision Healthcare during the 3rd quarter worth $229,000. Cutter & CO Brokerage Inc. boosted its position in Envision Healthcare by 11.1% during the 2nd quarter. Cutter & CO Brokerage Inc. now owns 3,668 shares of the company’s stock worth $230,000 after acquiring an additional 367 shares during the period. Finally, Flinton Capital Management LLC boosted its position in Envision Healthcare by 18.7% during the 2nd quarter. Flinton Capital Management LLC now owns 4,464 shares of the company’s stock worth $280,000 after acquiring an additional 704 shares during the period.
Envision Healthcare (NYSE EVHC) traded up $0.40 during trading hours on Tuesday, reaching $31.23. The company had a trading volume of 2,627,090 shares, compared to its average volume of 2,237,490. Envision Healthcare has a twelve month low of $23.77 and a twelve month high of $74.19. The firm has a market cap of $3,730.00, a price-to-earnings ratio of 9.49, a P/E/G ratio of 0.80 and a beta of 0.57. The company has a quick ratio of 3.00, a current ratio of 3.01 and a debt-to-equity ratio of 0.89.
Envision Healthcare declared that its Board of Directors has initiated a share buyback program on Monday, September 18th that allows the company to buyback $250.00 million in shares. This buyback authorization allows the company to buy up to 4.5% of its stock through open market purchases. Stock buyback programs are often a sign that the company’s board believes its stock is undervalued.
Envision Healthcare Company Profile
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Envision Healthcare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Co. and related companies with MarketBeat.com's FREE daily email newsletter.